KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Net Margin: 2009-2025

Historic Net Margin for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Sep 2025 value amounting to 35.20%.

  • Vertex Pharmaceuticals' Net Margin fell 251.00% to 35.20% in Q3 2025 from the same period last year, while for Sep 2025 it was 31.35%, marking a year-over-year increase of 3586.00%. This contributed to the annual value of -4.86% for FY2024, which is 4154.00% down from last year.
  • As of Q3 2025, Vertex Pharmaceuticals' Net Margin stood at 35.20%, which was up 1.03% from 34.84% recorded in Q2 2025.
  • Vertex Pharmaceuticals' Net Margin's 5-year high stood at 42.94% during Q3 2021, with a 5-year trough of -135.83% in Q2 2024.
  • Its 3-year average for Net Margin is 19.44%, with a median of 35.20% in 2025.
  • Per our database at Business Quant, Vertex Pharmaceuticals' Net Margin crashed by 17,256bps in 2024 and then skyrocketed by 17,067bps in 2025.
  • Over the past 5 years, Vertex Pharmaceuticals' Net Margin (Quarterly) stood at 37.16% in 2021, then crashed by 159bps to 35.56% in 2022, then spiked by 292bps to 38.48% in 2023, then tumbled by 713bps to 31.35% in 2024, then tumbled by 251bps to 35.20% in 2025.
  • Its Net Margin stands at 35.20% for Q3 2025, versus 34.84% for Q2 2025 and 23.33% for Q1 2025.